01 3Sobi Canada Inc
01 12793890
02 12885340
03 12887895
01 3LONCASTUXIMAB TESIRINE
01 3POWDER FOR SOLUTION
01 11931-04-15
02 21933-10-11
Patent Expiration Date : 1931-04-15
Date Granted : 2017-08-15
Brand Name : ZYNLONTA
Patent Number : 2793890
Filing Date : 2011-04-15
Strength per Unit : 10 mg
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 1931-04-15
Date Granted : 2017-08-15
Patent Expiration Date : 1933-10-11
Date Granted : 2016-11-08
Brand Name : ZYNLONTA
Patent Number : 2885340
Filing Date : 2013-10-11
Strength per Unit : 10 mg
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 1933-10-11
Date Granted : 2016-11-08
Patent Expiration Date : 1933-10-11
Date Granted : 2019-10-29
Brand Name : ZYNLONTA
Patent Number : 2887895
Filing Date : 2013-10-11
Strength per Unit : 10 mg
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 1933-10-11
Date Granted : 2019-10-29
